Orange County NC Website
Browse       Search
20 <br /> Enrollment Increases <br /> In addition to the cost of claims, employee enrollment in the County plan has increased over time. <br /> Enrollments have increased 7% over the past five (5) years. The most significant increases have <br /> occurred in employee-only plans which are 100% County funded. The number of enrollments for <br /> employee-only plans has increased by 12% over the past five (5) years, or by approximately 80 <br /> enrollments. <br /> Considerations for Cost Containment Measures <br /> Staff have explored several strategies to manage rising costs while maintaining current benefits <br /> and is recommending that the Board consider two changes to the health insurance plan design. <br /> 1. Implement a RxSaveCard for GLP-1's used for weight loss <br /> • The RxSaveCard offers a projected savings of $500,000 annually based on current <br /> utilization. <br /> • The RxSaveCard provides a mechanism for consumers to have direct relationships with <br /> GLP-1 drug manufacturers through Lilly Direct and NovoCare. <br /> • This direct-to-consumer relationship lowers the cost to the health plan by eliminating the <br /> premium associated with the Pharmacy Benefit Manager that would otherwise serve as <br /> an intermediary between the manufacturer, pharmacy, and consumer. For example, the <br /> cost of a Wegovy prescription under the County's current plan is $950 per month. The <br /> direct-to-consumer price is $350, saving the health plan $600 per month. <br /> • Instead of insurance plan coverage for this drug, employees would purchase medications <br /> directly from the manufacturer. In practice, employees would receive an RxSaveCard, <br /> and the County would provide a subsidy of$375 on this card each month for the employee <br /> to purchase their medication. If the actual cost of the prescription is less than the $375 <br /> monthly subsidy, the excess funding is returned to the County. For example, the direct- <br /> to-consumer price of the Wegovy injectable medication is$350. Since the County subsidy <br /> ($375) is greater than the direct-to-consumer cost, the employee receives the drug for$0, <br /> and $25 is returned to the County at the end of each month. The savings and cost to the <br /> employee under this plan are detailed in the table below. <br /> CURRENT PBM RxSaveCard <br /> Drug Dose Estimated Employee Direct Price OC Subsidy Employee <br /> Insurance Price Monthly monthly <br /> (after rebate) Cost(PPO) cost <br /> Wegovy(inj) all $950 $25 $350 $375 $0 <br /> Zepbound (inj) low $850 $25 $299 $375 $0 <br /> Zepbound (inj) mid $850 $25 $399 $375 $24 <br /> Zepbound (inj) high $850 $25 $449 $375 $74 <br /> Wegovy(oral) low $800 $25 $149 $375 $0 <br /> Wegovy (oral) mid $800 $25 $249 $375 $0 <br /> Wegovy(oral) high $800 $25 $229 $375 $0 <br /> • The only drug for which the employee would have to contribute is for the Zepbound <br /> injectable at medium and high doses. Those prescriptions would carry an employee <br /> responsibility of$24 and $74 respectively. The current co-pay under the County's current <br /> plan is $25. <br /> 2. Implement a Surcharge for Spousal Health Insurance Coverage when Alternative <br /> Coverage is available to the Spouse <br />